Last reviewed · How we verify
NCT05815030: PrEP4Kink
HIV Pre-Exposure Prophylaxis Among an Unrecognized Sexual Minority Population
NA trial testing video informational/educational intervention in Pre-Exposure Prophylaxis in 57 participants. Terminated before completion.
30 June 2024
Quick facts
| Lead sponsor | The Alternative Sexualities Health Research Alliance |
|---|---|
| Phase | NA |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 57 |
| Start date | 11 April 2023 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- video informational/educational intervention
Conditions studied
- Pre-Exposure Prophylaxis — all drugs for Pre-Exposure Prophylaxis →
Sponsor
The Alternative Sexualities Health Research Alliance
Who can join
18 and older, any sex, with Pre-Exposure Prophylaxis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The Alternative Sexualities Health Research Alliance (TASHRA) will work collaboratively with Gilead Sciences, Inc. to study Pre-Exposure Prophylaxis (PrEP) uptake and adherence; levels of stigma around PrEP use; and changes in health beliefs around PrEP use. The study design will compare kink-involved or bondage/discipline/dominance/submission/sadism/masochism (BDSM)-involved individuals responses to generic vs. kink-focused printed and educational-entertaining video materials in a 12 month crossover study. The primary objective of the study is to examine factors that increase the uptake of PrEP in a novel sexual subculture by testing the impact of an entertainment-education intervention designed to be highly relatable to kink-involved individuals. Secondary Objectives: PrEP4Kink will measure knowledge of PrEP and attitudes towards PrEP uptake over time. These are elements identified by the Health Belief Model: perceived risk of HIV; susceptibility to HIV; perceived barriers to PrEP uptake; perceived benefits of PrEP uptake; perceived effectiveness of PrEP; and self-efficacy of initiating PrEP uptake. Moderating and ancillary factors will be measured, and their relation to the elements of the Health Belief Model will be analyzed. Moderating factors include the centrality of kink identity; the level of kink community involvement; the types and frequencies of kink and sex behaviors. Demographic variables will be measured and their relation to elements of the Health Belief Model will be analyzed, including age; number of years involved in kink; gender identity; sex assigned at birth; racial/ethnic identity; educational attainment; income level; insurance coverage; sexual orientation identity; and sexual attraction.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05815030
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Pre-Exposure Prophylaxis
Currently open trials in the same condition.
- NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa · recruiting
- NCT06576648 — Thailand HIV and Stigma Reduction Study · NA · recruiting
- NCT05929521 — Centering Those Engaged in Transactional Sex: A PrEP Innovation for Getting To Zero · EARLY_PHASE1 · active not recruiting
- NCT06415357 — Zambia Healthy Choices Project for Emerging Adults Living With HIV · NA · active not recruiting
- NCT05262426 — Developing mHealth to Promote PrEP Use Among Thai Young Vulnerable Adolescents and Emerging Adults · NA · active not recruiting
Other The Alternative Sexualities Health Research Alliance trials
Trials by the same sponsor.
- NCT06969183 — A Descriptive Exploration of Flourishing Through Kink · completed
- NCT05318053 — International Kink Health Study · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05815030 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Alternative Sexualities Health Research Alliance
- Last refreshed: 25 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05815030.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing